Wafra Inc’s Dr. Reddy's Laboratories RDY Stock Holding History

Wafra Inc’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-35,000	Closed	-$447K	–	86
2015 Q3	$447K	Buy	+35,000	New	+$435K	0.05%	74

Other funds holding RDY

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wafra Inc's RDY Position: Q4 2015 in Review

Wafra Inc sold out of Dr. Reddy's Laboratories (RDY) in Q4 2015, closing a stake of 35,000 shares — an estimated $447K sold.

Wafra Inc first reported a position in RDY in Q3 2015 and held it in 1 quarter. The position peaked at $447K in Q3 2015. 174 funds tracked by Wall St. Rank hold RDY as of Q4 2015.

Wafra Inc reported no remaining Dr. Reddy's Laboratories position as of Q4 2015 after selling out during the quarter.
Wafra Inc sold 35,000 Dr. Reddy's Laboratories shares in Q4 2015, an estimated $447K.
Wafra Inc first reported a position in Dr. Reddy's Laboratories in Q3 2015 and held it in 1 quarter.
Wafra Inc's Dr. Reddy's Laboratories position peaked at $447K in Q3 2015.
174 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2015.

Based on Wafra Inc's 13F filing for Q4 2015, filed 11 Feb 2016.